Short Interest in Immatics (NASDAQ:IMTXW) Grows By 28.6%

Immatics (NASDAQ:IMTXW) saw a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 900 shares, a growth of 28.6% from the October 31st total of 700 shares. Based on an average daily volume of 17,800 shares, the days-to-cover ratio is presently 0.1 days.

Immatics Trading Down 20.2 %

IMTXW stock traded down $0.10 during midday trading on Monday, reaching $0.40. The stock had a trading volume of 959,351 shares, compared to its average volume of 16,574. The company’s fifty day simple moving average is $1.23 and its 200 day simple moving average is $2.29. Immatics has a 52-week low of $0.35 and a 52-week high of $4.14.

About Immatics

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics.